Cargando…
Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD
Chimeric antigen receptor (CAR) T cell therapy is an effective salvage therapy for pediatric relapsed B-cell acute lymphoblastic leukemia (B-ALL), yet is challenged by high rates of post-CAR relapse. Literature describing specific relapse patterns and extramedullary (EM) sites of involvement in the...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972424/ https://www.ncbi.nlm.nih.gov/pubmed/36849202 http://dx.doi.org/10.1136/jitc-2022-004851 |
_version_ | 1784898320873816064 |
---|---|
author | Schultz, Liora Davis, Kara Lynn Walkush, Ann Baggott, Christina Erickson, Courtney Ramakrishna, Sneha Aftandilian, Catherine Lacayo, Norman Nadel, Helen Ruth Oak, Jean Mackall, Crystal L |
author_facet | Schultz, Liora Davis, Kara Lynn Walkush, Ann Baggott, Christina Erickson, Courtney Ramakrishna, Sneha Aftandilian, Catherine Lacayo, Norman Nadel, Helen Ruth Oak, Jean Mackall, Crystal L |
author_sort | Schultz, Liora |
collection | PubMed |
description | Chimeric antigen receptor (CAR) T cell therapy is an effective salvage therapy for pediatric relapsed B-cell acute lymphoblastic leukemia (B-ALL), yet is challenged by high rates of post-CAR relapse. Literature describing specific relapse patterns and extramedullary (EM) sites of involvement in the post-CAR setting remains limited, and a clinical standard for post-CAR disease surveillance has yet to be established. We highlight the importance of integrating peripheral blood minimal residual disease (MRD) testing and radiologic imaging into surveillance strategies, to effectively characterize and capture post-CAR relapse. Main body: Here, we describe the case of a child with multiply relapsed B-ALL who relapsed in the post-CAR setting with gross non-contiguous medullary and EM disease. Interestingly, her relapse was identified first from peripheral blood flow cytometry MRD surveillance, in context of a negative bone marrow aspirate (MRD <0.01%). Positron emission tomography with 18F-fluorodeoxyglucose revealed diffuse leukemia with innumerable bone and lymph node lesions, interestingly sparing her sacrum, the site of her bone marrow aspirate sampling. Conclusions: We highlight this case as both peripheral blood MRD and 18F-fluorodeoxyglucose positron emission tomography imaging were more sensitive than standard bone marrow aspirate testing in detecting this patient’s post-CAR relapse. Clinical/Biologic Insight: In the multiply relapsed B-ALL setting, where relapse patterns may include patchy medullary and/or EM disease, peripheral blood MRD and/or whole body imaging, may carry increased sensitivity at detecting relapse in patient subsets, as compared with standard bone marrow sampling. |
format | Online Article Text |
id | pubmed-9972424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-99724242023-03-01 Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD Schultz, Liora Davis, Kara Lynn Walkush, Ann Baggott, Christina Erickson, Courtney Ramakrishna, Sneha Aftandilian, Catherine Lacayo, Norman Nadel, Helen Ruth Oak, Jean Mackall, Crystal L J Immunother Cancer Case Report Chimeric antigen receptor (CAR) T cell therapy is an effective salvage therapy for pediatric relapsed B-cell acute lymphoblastic leukemia (B-ALL), yet is challenged by high rates of post-CAR relapse. Literature describing specific relapse patterns and extramedullary (EM) sites of involvement in the post-CAR setting remains limited, and a clinical standard for post-CAR disease surveillance has yet to be established. We highlight the importance of integrating peripheral blood minimal residual disease (MRD) testing and radiologic imaging into surveillance strategies, to effectively characterize and capture post-CAR relapse. Main body: Here, we describe the case of a child with multiply relapsed B-ALL who relapsed in the post-CAR setting with gross non-contiguous medullary and EM disease. Interestingly, her relapse was identified first from peripheral blood flow cytometry MRD surveillance, in context of a negative bone marrow aspirate (MRD <0.01%). Positron emission tomography with 18F-fluorodeoxyglucose revealed diffuse leukemia with innumerable bone and lymph node lesions, interestingly sparing her sacrum, the site of her bone marrow aspirate sampling. Conclusions: We highlight this case as both peripheral blood MRD and 18F-fluorodeoxyglucose positron emission tomography imaging were more sensitive than standard bone marrow aspirate testing in detecting this patient’s post-CAR relapse. Clinical/Biologic Insight: In the multiply relapsed B-ALL setting, where relapse patterns may include patchy medullary and/or EM disease, peripheral blood MRD and/or whole body imaging, may carry increased sensitivity at detecting relapse in patient subsets, as compared with standard bone marrow sampling. BMJ Publishing Group 2023-02-27 /pmc/articles/PMC9972424/ /pubmed/36849202 http://dx.doi.org/10.1136/jitc-2022-004851 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Case Report Schultz, Liora Davis, Kara Lynn Walkush, Ann Baggott, Christina Erickson, Courtney Ramakrishna, Sneha Aftandilian, Catherine Lacayo, Norman Nadel, Helen Ruth Oak, Jean Mackall, Crystal L Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD |
title | Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD |
title_full | Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD |
title_fullStr | Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD |
title_full_unstemmed | Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD |
title_short | Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD |
title_sort | role of peripheral blood mrd and 18f-fdg pet in the post-car relapse setting: a case study of discordant peripheral blood and bone marrow mrd |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972424/ https://www.ncbi.nlm.nih.gov/pubmed/36849202 http://dx.doi.org/10.1136/jitc-2022-004851 |
work_keys_str_mv | AT schultzliora roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT daviskaralynn roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT walkushann roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT baggottchristina roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT ericksoncourtney roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT ramakrishnasneha roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT aftandiliancatherine roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT lacayonorman roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT nadelhelenruth roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT oakjean roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd AT mackallcrystall roleofperipheralbloodmrdand18ffdgpetinthepostcarrelapsesettingacasestudyofdiscordantperipheralbloodandbonemarrowmrd |